Drug intelligence / Profile preview

recombinant type III humanized collagen + sodium hyaluronate

Development stage
Unknown
Lead developer
Shanxi Jinbo Bio-Pharmaceutical
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Injectable (dermal/facial), Topical (liquid Dressing)
01

Overview

This is a combination medical product consisting of recombinant type III humanized collagen and sodium hyaluronate (hyaluronic acid). Recombinant type III humanized collagen is produced via genetic engineering to closely mimic natural human type III collagen, which plays a key role in skin structure and wound healing. Sodium hyaluronate is a form of hyaluronic acid that provides hydration and supports tissue repair. The combination acts as a dermal filler or topical dressing for skin repair, facial wrinkle correction (including forehead lines, glabellar lines, crow’s feet), scar improvement, and wound healing. Mechanistically, the recombinant collagen integrates into the extracellular matrix to support cell growth and tissue regeneration while reducing the ratio of type I/III collagen—an effect associated with improved scar outcomes. Sodium hyaluronate enhances moisture retention and further promotes healing by creating an optimal environment for cell migration and proliferation[5][6][8]. This product has been approved in China as both an injectable implantable device for aesthetic indications (e.g., dynamic wrinkles) and as a topical liquid dressing for minor wounds[5][8].

Brand names
欣适妍
Other names
重组Ⅲ型人源化胶原蛋白 + 透明质酸钠recombinant type III humanized collagen + sodium hyaluronate重组胶原蛋白+透明质酸钠液体敷料
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on recombinant type III humanized collagen + sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant type III humanized collagen + sodium hyaluronate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call